Evan Merrill, DPM
Foot Surgery · Medford, ORNPI 1528166485
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 94.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $7,881 and has fallen 82.8% since, to $1,358 in 2025.
Across 84 payments — averaging $186.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$15K
- Stryker$269
- Paratek Pharmaceuticals, Inc.$211
- Integra Lifesciences Corporation$69
- Mimedx Group, Inc.$66
- DJO, LLC$49
- plus $205 from 10 others
What the payments were for
- Consulting fees$5,39034%
- Travel & lodging$7,12645%
- Food & beverage$3,13420%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 57 | $14,794 |
| Stryker(2 entities) | 6 | $269 |
| Paratek Pharmaceuticals, Inc. | 1 | $211 |
| Integra Lifesciences Corporation | 1 | $69 |
| Mimedx Group, Inc. | 3 | $66 |
| DJO, LLC | 3 | $49 |
| Merck | 3 | $48 |
| Smith+Nephew | 2 | $33 |
| Organogenesis Inc. | 1 | $26 |
| Acera Surgical, Inc. | 1 | $24 |
| KCI USA, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Rikco International, LLC | 1 | $12 |
| Medela LLC | 1 | $11 |
| Orthofix Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$12,610
- Lapiplasty$798
- NUZYRA$211
- AUGMENT INJECTABLE$146
- CITREFIX$146
How this compares
Too few foot surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 136 | $1,373 |
| Pregabalin | 17 | $1,129 |
| Terbinafine Hcl | 52 | $951 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 51 | $541 |
| Doxycycline Monohydrate | 14 | $137 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $124 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $98 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Medford
- Michael MatthewsSalem$1K
- Bettricia OttoPortland$682
- Thuy LamClackamas$638
- Joseph NearyClackamas$539
- Ambrose SuBend$319
- Brian AshdownAlbany$202
- Darrin DalleggeEugene$193
- Patricia CainOregon City$189
- Steven TillettPortland$185
- David GreenbergPortland$146
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.